GHIT Fund announces new investments to develop drugs, vaccines, diagnostics for malaria, TB, NTDs

The Global Health Innovative Technology (GHIT) Fund announced a total of 3.29 billion yen (US$30 million) to invest in 11 partnerships to develop new lifesaving drugs, vaccines and diagnostics for malaria, TB, Chagas disease, leishmaniasis, lymphatic filariasis, onchocerciasis, and mycetoma. This includes five new projects and six that will receive continued funding.